SCHEMBL1079110

SCHEMBL1079110

COc1ccc2ccc(=O)n(Br)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
KMT2A Q03164 2/20 0.44
GSTP1 P09211 1/20 0.43
MEN1 O00255 1/20 0.43
MAOB P27338 1/20 0.43
CA2 P00918 1/20 0.43
CYP2A6 P11509 2/20 0.42
CYP1A2 P05177 1/20 0.42
KDM4E B2RXH2 2/20 0.42
CA12 O43570 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CA1 P00915 1/20 0.42
CA3 P07451 1/20 0.42
AKR1B1 P15121 1/20 0.42
HPGD P15428 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19231462 0.80 CA2 (0.55) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL27947016 0.79 MAPT (0.45) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL9499453 0.79 SMN1; SMN2 (0.45) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL20710538 0.76 MAPT (0.67) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL30405786 0.73 KDM4E (0.57) SMN1; SMN2CA2CYP1A2KDM4EALDH1A1
SCHEMBL2799244 0.72 MAPT (0.50) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL10285843 0.72 MAPT (0.50) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL6074279 0.71 BRPF1 (0.59) MAPTSMN1; SMN2KMT2AGSTP1MEN1
SCHEMBL3839888 0.71 TNFRSF1A (0.52) MAPTSMN1; SMN2NPSR1RXFP1KMT2A
SCHEMBL4305274 0.71 MAPT (0.49) MAPTSMN1; SMN2NPSR1RXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268285-A1 THERAPEUTIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2011-01-05 EP disclosed
WO-2009108507-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2009-09-03 WO disclosed